Type 2 diabetes (T2D) associated with obesity is accompanied not only by metabolic but also cardiovascular disorders, including impaired vascular function. In addition to nitric oxide (NO), another gaseous transmitter, hydrogen sulfide (H2S), plays a key role in vascular homeostasis, but its function under pathological conditions is not fully understood. Escalated metabolic disorder associated with T2D could disrupt sulfide signaling and shift the balance between its pathological and compensatory action. The aim of the study was to investigate the role of H2S and NO signaling in the vascular function of obese Zucker diabetic fatty (ZDF) rats and to evaluate the impact of chronic treatment with zofenopril, an ACE inhibitor containing a sulfhydryl group. Cardiometabolic and biochemical parameters, as well as reactivity of the isolated thoracic aorta after 4 weeks of treatment, were assessed. Obese rats exhibited increased systolic blood pressure (SBP), cardiac and renal hypertrophy, increased adiposity, dyslipidemia, and impaired glucose tolerance compared with controls. Endothelium-dependent relaxation was reduced, with loss of H2S-derived relaxant component and dysregulation of NO signaling. Zofenopril significantly reduced SBP, attenuated cardiac and renal hypertrophy, and restored endothelial and contractile function. At the molecular level, it increased the expression of H2S-synthesizing enzymes, restored H2S-dependent vasorelaxation, and normalized NOS activity with a predominance of eNOS. In conclusion, zofenopril restored the balance of H2S and NO signaling in obese ZDF rats, thereby providing cardiovascular protection independent of improvements in glycemia or lipid profile. This dual mechanism may represent a promising therapeutic approach in preventing complications of obesity-induced T2D.

Institute of Normal and Pathological Physiology Centre of Experimental Medicine Slovak Academy of Sciences Bratislava Slovakia

Zobrazit více v PubMed

Islam RA, Han X, Shaligram S, Esfandiarei M, Stallone JN, Rahimian R. Sexual dimorphism in impairment of acetylcholine-mediated vasorelaxation in zucker diabetic fatty (zdf) rat aorta: a monogenic model of obesity-induced type 2 diabetes. Int J Mol Sci. 2024;25:11328. doi: 10.3390/ijms252011328. PubMed DOI PMC

Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE, et al. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia. 2010;53:1722–1726. doi: 10.1007/s00125-010-1761-5. PubMed DOI

Mitidieri E, Turnaturi C, Vanacore D, Sorrentino R, d’Emmanuele di Villa Bianca R. The role of perivascular adipose tissue-derived hydrogen sulfide in the control of vascular homeostasis. Antioxid Redox Signal. 2022;37:84–97. doi: 10.1089/ars.2021.0147. PubMed DOI

Berenyiova A, Golas S, Drobna M, Cebova M, Cacanyiova S. Fructose Intake Impairs the Synergistic Vasomotor Manifestation of Nitric Oxide and Hydrogen Sulfide in Rat Aorta. Int J Mol Sci. 2021;22:4749. doi: 10.3390/ijms22094749. PubMed DOI PMC

Berenyiova A, Bernatova I, Zemancikova A, Drobna M, Cebova M, Golas S, Balis P, et al. Vascular effects of low-dose ACE2 inhibitor MLN-4760-benefit or detriment in essential hypertension? Biomedicines. 2021;10:38. doi: 10.3390/biomedicines10010038. PubMed DOI PMC

Cacanyiova S, Berenyiova A, Malinska H, Huttl M, Markova I, Aydemir BG, Garaiova V, et al. Female prediabetic rats are protected from vascular dysfunction: the role of nitroso and sulfide signaling. Biol Res. 2024;57:91. doi: 10.1186/s40659-024-00575-1. PubMed DOI PMC

Xia Y, Zhang W, He K, Bai L, Miao Y, Liu B, Zhang X, Jin S, et al. Hydrogen sulfide alleviates lipopolysaccharide-induced myocardial injury through TLR4-NLRP3 pathway. Physiol Res. 2023;72:15–25. doi: 10.33549/physiolres.934928. PubMed DOI PMC

Citi V, Martelli A, Gorica E, Brogi S, Testai L, Calderone V. Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches. J Adv Res. 2020;27:99–113. doi: 10.1016/j.jare.2020.05.015. PubMed DOI PMC

Cacanyiova S, Cebova M, Simko F, Baka T, Bernatova I, Kluknavsky M, Zorad S, et al. The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760. Biol Res. 2023;56:55. doi: 10.1186/s40659-023-00466-x. PubMed DOI PMC

Cebova M, Klimentova J, Janega P, Pechanova O. Effect of bioactive compound of aronia melanocarpa on cardiovascular system in experimental hypertension. Oxid Med Cell Longev. 2017;2017:8156594. doi: 10.1155/2017/8156594. PubMed DOI PMC

Kluknavsky M, Micurova A, Cebova M, Şaman E, Cacanyiova S, Bernatova I. MLN-4760 Induces oxidative stress without blood pressure and behavioural alterations in shrs: roles of Nfe2l2 gene, nitric oxide and hydrogen sulfide. Antioxidants. 2022;11:2385. doi: 10.3390/antiox11122385. PubMed DOI PMC

Shen X, Pattillo CB, Pardue S, Bir SC, Wang R, Kevil CG. Measurement of plasma hydrogen sulfide in vivo and in vitro. Free Radic Biol Med. 2011;50:1021–1031. doi: 10.1016/j.freeradbiomed.2011.01.025. PubMed DOI PMC

DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10:364–376. doi: 10.1038/nrendo.2014.44. PubMed DOI PMC

Xia N, Li H. The role of perivascular adipose tissue in obesity-induced vascular dysfunction. Br J Pharmacol. 2017;174:3425–3442. doi: 10.1111/bph.13650. PubMed DOI PMC

Donnarumma E, Ali MJ, Rushing AM, Scarborough AL, Bradley JM, Organ CL, Islam KN, et al. Zofenopril protects against myocardial ischemia-reperfusion injury by increasing nitric oxide and hydrogen sulfide bioavailability. J Am Heart Assoc. 2016;5:e003531. doi: 10.1161/JAHA.116.003531. PubMed DOI PMC

Borghi C, Omboni S. Angiotensin-converting enzyme inhibition: beyond blood pressure control-the role of zofenopril. Adv Ther. 2020;37:4068–4085. doi: 10.1007/s12325-020-01455-2. PubMed DOI

Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res. 2021;18:14791641211058856. doi: 10.1177/14791641211058856. PubMed DOI PMC

Bhandari U, Kumar V, Khanna N, Panda BP. The effect of high-fat diet-induced obesity on cardiovascular toxicity in Wistar albino rats. Hum Exp Toxicol. 2011;30(9):1313–1321. doi: 10.1177/0960327110389499. PubMed DOI

Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97:1784–1789. doi: 10.1073/pnas.97.4.1784. PubMed DOI PMC

Egan Beňová T, Sýkora M, Ondreják Andelová K, Farkašová V, Lepáček M, Šoltésová Prnová M, Babál P, et al. Brown adipose tissue: a potential therapeutic target for preventing cardiovascular disease in metabolic disorders. Diabetol Metab Syndr. 2025;17:311. doi: 10.1186/s13098-025-01892-5. PubMed DOI PMC

Rizos EC, Tsouli S, Doumas M, Kostapanos M, Lagos K, Tselepis AD, Elisaf M. Improvement of the lipid profile with zofenopril in hypertensive patients with the metabolic syndrome. Open Clin Chem J. 2008;1:64–68. doi: 10.2174/1874241600801010064. DOI

Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K. Substitution at codon 269 (glutamine --> proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun. 1996;224:597–604. doi: 10.1006/bbrc.1996.1070. PubMed DOI

Lacourcière Y, Gagné C. Influence of zofenopril and low doses of hydrochlorothiazide on plasma lipoproteins in patients with mild to moderate essential hypertension. Am J Hypertens. 1989;2(11 Pt 1):861–864. doi: 10.1093/ajh/2.11.861. PubMed DOI

Oltman CL, Richou LL, Davidson EP, Coppey LJ, Lund DD, Yorek MA. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol. 2006;291:H1780–H1787. doi: 10.1152/ajpheart.01297.2005. PubMed DOI

Trovato FM, Castrogiovanni P, Szychlinska MA, Purrello F, Musumeci G. Impact of Western and Mediterranean diets and vitamin D on muscle fibers of sedentary rats. Nutrients. 2018;10:231. doi: 10.3390/nu10020231. PubMed DOI PMC

Berenyiova A, Cebova M, Aydemir BG, Golas S, Majzunova M, Cacanyiova S. Vasoactive Effects of Chronic Treatment with Fructose and Slow-Releasing H2S Donor GYY-4137 in Spontaneously Hypertensive Rats: The Role of Nitroso and Sulfide Signalization. Int J Mol Sci. 2022;23:9215. doi: 10.3390/ijms23169215. PubMed DOI PMC

Cacanyiova S, Krskova K, Zorad S, Frimmel K, Drobna M, Valaskova Z, Misak A, Golas S, Breza J, Breza J, Jr, et al. Arterial hypertension and plasma glucose modulate the vasoactive effects of nitroso-sulfide coupled signaling in human intrarenal arteries. Molecules. 2020;25:2886. doi: 10.3390/molecules25122886. PubMed DOI PMC

Cacanyiova S, Golas S, Zemancikova A, Majzunova M, Cebova M, Malinska H, Hüttl M, et al. The vasoactive role of perivascular adipose tissue and the sulfide signaling pathway in a nonobese model of metabolic syndrome. Biomolecules. 2021;11:108. doi: 10.3390/biom11010108. PubMed DOI PMC

Cacanyiova S, Majzunova M, Golas S, Berenyiova A. The role of perivascular adipose tissue and endogenous hydrogen sulfide in vasoactive responses of isolated mesenteric arteries in normotensive and spontaneously hypertensive rats. J Physiol Pharmacol. 2019:70. doi: 10.26402/jpp.2019.2.13. PubMed DOI

Katsouda A, Szabo C, Papapetropoulos A. Reduced adipose tissue H2S in obesity. Pharmacol Res. 2018;128:190–199. doi: 10.1016/j.phrs.2017.09.023. PubMed DOI

Candela J, Wang R, White C. Microvascular Endothelial Dysfunction in Obesity Is Driven by Macrophage-Dependent Hydrogen Sulfide Depletion. Arterioscler Thromb Vasc Biol. 2017;37:889–899. doi: 10.1161/ATVBAHA.117.309138. PubMed DOI

Leo CH, Hart JL, Woodman OL. 3’,4’-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries. PLoS One. 2011;6:e20813. doi: 10.1371/journal.pone.0020813. PubMed DOI PMC

van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192:1731–1744. doi: 10.1084/jem.192.12.1731. PubMed DOI PMC

Bucci M, Vellecco V, Cantalupo A, Brancaleone V, Zhou Z, Evangelista S, Calderone V, et al. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. Cardiovasc Res. 2014;102:138–147. doi: 10.1093/cvr/cvu026. PubMed DOI

Terzuoli E, Monti M, Vellecco V, Bucci M, Cirino G, Ziche M, Morbidelli L. Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2S availability. Br J Pharmacol. 2015;172:2961–2973. doi: 10.1111/bph.13101. PubMed DOI PMC